Related Experiment Videos
Hypertension and diabetes
Ehud Grossman1, Franz H Messerli
1Department of Internal Medicine D and Hypertension Unit, The Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Insights
Hypertension and diabetes significantly increase cardiovascular risk by damaging blood vessels. Effective management involves aggressive blood pressure control and choosing medications beneficial for metabolic profiles.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- Essential hypertension and diabetes mellitus share common target organ damage, primarily affecting the vascular tree.
- Combined hypertension and diabetes accelerate renal function decline, diabetic retinopathy, and cerebral diseases.
- Left ventricular hypertrophy and coronary artery disease are more prevalent in patients with both conditions.
Purpose of the Study:
- To outline the impact of combined hypertension and diabetes on target organ damage.
- To discuss optimal blood pressure management strategies in diabetic patients.
- To review the effects of different antihypertensive drug classes on metabolic risk factors.
Main Methods:
- Review of existing literature on the pathophysiology and management of coexisting hypertension and diabetes.
- Analysis of the effects of various antihypertensive medications on cardiovascular and metabolic risk profiles.
- Discussion of combination therapy and adjunct treatments for resistant hypertension.
Main Results:
- Beta-blockers may negatively impact the metabolic risk factor profile in diabetic patients.
- Calcium antagonists, ACE inhibitors, and ARBs are neutral or beneficial for metabolic profiles.
- Combination therapy is often necessary to achieve blood pressure goals in diabetic patients.
Conclusions:
- Aggressive control of blood pressure, cholesterol, and glucose is crucial for reducing cardiovascular risk in hypertensive diabetic patients.
- Medication choice is critical, favoring agents with neutral or beneficial metabolic effects.
- Aldosterone antagonists may benefit specific patient groups with resistant hypertension.
Abstract:
Both essential hypertension and diabetes mellitus affect the same major target organs. The common denominator of hypertensive/diabetic target organ-disease is the vascular tree. Left ventricular hypertrophy and coronary artery disease are much more common in diabetic hypertensive patients than in patients suffering from hypertension or diabetes alone. The combined presence of hypertension and diabetes concomitantly accelerates the decrease in renal function, the development of diabetic retinopathy and the development of cerebral diseases. Lowering blood pressure to less than 130/80 mm Hg is the primary goal in the management of the hypertensive diabetic patients. Beta-blockers have been reported to adversely affect the overall risk factor profile in the diabetic patient. In contrast, calcium antagonists, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have been reported to be either neutral or beneficial with regard to the overall metabolic risk factor profile. Combination therapy is usually required to achieve blood pressure goal in diabetic patients. The addition of aldosterone antagonists may be beneficial in patients with resistant hypertension and low levels of serum potassium. Aggressive control of blood pressure, cholesterol and glucose levels should be attempted to reduce the cardiovascular risk of diabetic hypertensive patients.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension II: Pathophysiology
Alterations in Blood Pressure
Hypertension (High blood pressure)
Hypertension occurs when blood pressure readings consistently exceed the normal range. It is diagnosed when systolic blood pressure (the top number, indicating pressure while the heart beats)...
Diabetic Nephropathy
Hyperglycemia